Koers TCR2 Therapeutics Inc.
Aandelen
TCRR
US87808K1060
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Garry Menzel
CEO | Chief Executive Officer | 59 | 01-01-16 |
William Bertrand
PSD | President | 59 | 01-06-23 |
Robert Tighe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Garry Menzel
CEO | Chief Executive Officer | 59 | 01-01-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,16% | 45,97 mld. | |
+53,86% | 43,93 mld. | |
+11,20% | 42,34 mld. | |
-8,59% | 28,27 mld. | |
+16,40% | 27,18 mld. | |
-19,34% | 19,44 mld. | |
+13,95% | 13,83 mld. | |
+31,56% | 12,4 mld. | |
+10,63% | 11,45 mld. |